Published in Ann Med on December 01, 1997
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Killer system: a simple method for differentiating Candida albicans strains. J Clin Microbiol (1983) 8.05
Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A (1997) 5.83
Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol (2001) 5.03
The E2F1-3 transcription factors are essential for cellular proliferation. Nature (2001) 4.37
The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res (2001) 3.02
Ras enhances Myc protein stability. Mol Cell (1999) 2.91
The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol (1996) 2.47
Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci U S A (1998) 2.40
Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study. Neurology (2005) 2.18
Analysis of the microtopography of the skin by silicone replicas after repeated exposure to actinic radiation at high altitudes. J Eur Acad Dermatol Venereol (2001) 2.04
Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplant (2007) 2.03
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98
Office normotensives with a minimal augmentation of intima-media thickness of common carotid arteries: really normotensives? Eur Rev Med Pharmacol Sci (2013) 1.97
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med (1999) 1.97
E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ (1998) 1.96
E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev (1995) 1.95
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis (2007) 1.94
Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Leukemia (2008) 1.92
The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia (2006) 1.92
Treatment of a vertebral dissecting aneurysm with stents and coils: technical case report. Neurosurgery (1998) 1.85
Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol Cell Biol (1996) 1.83
Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol (2001) 1.83
Influence of rehabilitation on language skills in aphasic patients. A controlled study. Arch Neurol (1979) 1.79
Effect of shift work on body mass index: results of a study performed in 319 glucose-tolerant men working in a Southern Italian industry. Int J Obes Relat Metab Disord (2003) 1.69
Brief report: disseminated mycobacteriosis caused by drug-resistant Mycobacterium triplex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy. Clin Infect Dis (2000) 1.65
Electrocardiographic signs of chronic cor pulmonale: A negative prognostic finding in chronic obstructive pulmonary disease. Circulation (1999) 1.63
Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J Acquir Immune Defic Syndr (1999) 1.63
Functional analysis of E2F transcription factor. Methods Enzymol (1997) 1.59
Screening of JAK2 V617F mutation in multiple myeloma. Leukemia (2006) 1.59
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol (2001) 1.57
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J Infect Dis (1999) 1.56
Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc Natl Acad Sci U S A (1994) 1.51
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. Blood (1988) 1.50
Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis. Leukemia (2003) 1.49
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci U S A (2001) 1.48
Evaluation of a nonradiometric system (BACTEC 9000 MB) for detection of mycobacteria in human clinical samples. J Clin Microbiol (1997) 1.48
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood (1998) 1.47
Role of the Rb/E2F pathway in cell growth control. J Cell Physiol (1997) 1.44
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. J Clin Microbiol (1998) 1.43
Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med (1995) 1.42
Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitors. Br J Haematol (1997) 1.42
Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol (1994) 1.42
Autologous graft-versus-host disease after CD34+-purified autologous peripheral blood progenitor cell transplantation. J Hematother Stem Cell Res (2000) 1.41
Antithrombin III in patients with hepatocellular carcinoma. Thromb Haemost (1987) 1.39
Mortality related to thrombosis in congenital antithrombin III deficiency. Lancet (1991) 1.39
Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis (1990) 1.34
Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol Cell Biol (2000) 1.32
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.32
Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost (1998) 1.31
[Controlled study of language re-education in aphasia: comparison between treated and untreated aphasics]. Rev Neurol (Paris) (1975) 1.30
Studies on the epidemiology of Aspergillus fumigatus infections in a university hospital. Eur J Epidemiol (1989) 1.29
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost (2007) 1.28
Reevaluation of the yeast killer phenomenon. J Clin Microbiol (1986) 1.28
A fMRI study of word retrieval in aphasia. Brain Lang (2003) 1.27
Biochemical and biophysical characterization of the reovirus cell attachment protein sigma 1: evidence that it is a homotrimer. Virology (1991) 1.25
Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol (2012) 1.24
Use of killer toxins for computer-aided differentiation of Candida albicans strains. Mycopathologia (1985) 1.22
The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost (2005) 1.22
Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia (2002) 1.22
Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Hum Mol Genet (2001) 1.20
Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur J Haematol (1999) 1.19
Serological analysis of dermatophyte isolates with monoclonal antibodies produced against Microsporum canis. J Clin Microbiol (1985) 1.17
Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J Biol Chem (2001) 1.17
Strain differentiation of pathogenic yeasts by the killer system. Mycopathologia (1984) 1.16
The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene (2010) 1.15
Clinical trial of xipamide in the treatment of hypertension. J Int Med Res (1980) 1.15
Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ (1998) 1.15
Neuropsychological evidence for the existence of cerebral areas critical to the performance of intelligence tasks. Brain (1973) 1.14
CD105 (endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymphoma (2002) 1.13
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. Blood (1997) 1.13
PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies. J Clin Microbiol (1999) 1.12
Therapy related leukemias: susceptibility, prevention and treatment. Leuk Lymphoma (2001) 1.11
NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey. Ann Oncol (2006) 1.10
Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis (2004) 1.10
Anatomoclinical correlations of the aphasias as defined through computerized tomography: exceptions. Brain Lang (1985) 1.09
Conformational and functional analysis of the C-terminal globular head of the reovirus cell attachment protein. Virology (1991) 1.08
Is ideomotor apraxia the outcome of damage to well-defined regions of the left hemisphere? Neuropsychological study of CAT correlation. J Neurol Neurosurg Psychiatry (1980) 1.08
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia. Br J Cancer (2006) 1.08
Multiple polymorphic sites in factor X locus. Blood (1988) 1.07
Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Br J Haematol (1999) 1.07
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Ann Oncol (2011) 1.07
Binding of reovirus to receptor leads to conformational changes in viral capsid proteins that are reversible upon virus detachment. J Biol Chem (1994) 1.06
Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.06
Quality of life in patients with traumatic brain injury-basic issues, assessment and recommendations. Restor Neurol Neurosci (2002) 1.06
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. Oncogene (2007) 1.05
The anti-schistosomal drug praziquantel is an adenosine antagonist. Parasitology (2007) 1.05
Nosocomial outbreak of systemic candidosis associated with parenteral nutrition. Infect Control Hosp Epidemiol (1990) 1.05
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. Ann Oncol (2009) 1.03
Dissociated disorders of speaking and writing in aphasia. J Neurol Neurosurg Psychiatry (1978) 1.03
Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates. J Clin Microbiol (1999) 1.03
Characterization and complete nucleotide sequence of Strawberry mottle virus: a tentative member of a new family of bipartite plant picorna-like viruses. J Gen Virol (2002) 1.02
Fractal characterisation of boundary irregularity in skin pigmented lesions. Med Biol Eng Comput (2005) 1.02
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia (2013) 1.01